Pharma channel feed – Endpoints News

Pharma channel feed

Safety concerns lead to a split FDA panel vote on Sanofi/Lexicon diabetes drug

7 years ago

Celgene inks first deals since Bristol-Myers announced $74B buyout — bets $80M on immunometabolism

7 years ago

Scoop: Forma axes discovery biology team as part of a broader reorganization

7 years ago

With J&J deal to assess value of Apple watch in atrial fibrillation, tech giant fortifies its foray into healthcare

7 years ago

Looking to make a splash at JPMorgan, Eli Lilly rushed to put its $8B buyout deal together for Loxo in 10 days

7 years ago

FDA revises draft guidance on rare disease drug R&D

7 years ago

Dragonfly preps clinical takeoff, inking a collaboration pact with MD Anderson

7 years ago

Five Prime cuts 41 jobs, days before presenting data at ASCO meeting of GI cancers

7 years ago

Gottlieb, Marks detail plans to advance development of cell and gene therapies

7 years ago

In a first, China’s BeiGene scores FDA ‘breakthrough’ status for BTK inhibitor — potential rival for Imbruvica

7 years ago

Cummings triggers probe into pricing practices of dozen major drugmakers

7 years ago

Aimmune says US government shutdown stymied its peanut allergy drug application

7 years ago

Scoop: Pfizer once again takes out the budget ax, lopping off 150 R&D staffers and 5 preclinical biosimilar drugs

7 years ago

EMA to lose 25% of staff as hard Brexit approaches

7 years ago

Is JPM worth it? As the buzzy conference dies down, debate on its value rumbles on

7 years ago

FDA staff largely unfazed by CV signal in Amgen osteoporosis drug trials

7 years ago

J&J hikes US prices for a basket of drugs, including certain top-sellers — Reuters

7 years ago

As JPMorgan madness subsides, Democrats will unveil a legislative package to address drug price hikes

7 years ago

The first patient has been treated under the controversial 'right to try' law

7 years ago

Denali broadens tech to infiltrate the blood-brain barrier with Sirion deal

7 years ago

Anti-aging startup Unity dives into eye diseases as partnership with Ascentage bears fruit

7 years ago

‘It’s us against the world’: And George Yancopoulos wants you to know they are beating the world — big time

7 years ago

Bluebird endorses plan for installment-based payments for costly gene therapy

7 years ago

Billed as potential blockbuster, Novartis' sickle cell drug scores FDA's breakthrough therapy status

7 years ago

First page Previous page 282 283 284285286 287 288 Next page Last page